Atlas Trials

The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients

Clinical trial NCT02103049 · COMPLETED

Trial details

NCT number
NCT02103049
Sponsor
University Medical Centre Ljubljana
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DyslipidemiaTransplants
Start date
2014-04-01
Primary completion
2015-11-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.